Compare Appian Corp (APPN) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Appian Corp vs Zimmer Biomet Holdings Inc — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 7.3× Appian Corp's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Appian Corp pays none. Which is the better fit depends on your goals.
| APPN | ZBH | |
|---|---|---|
Market Cap | $2.54B | $18.55B |
Sector | Technology | Health |
52-Week High | $45.64 | $107.71 |
52-Week Low | $18.72 | $79.58 |
Enterprise Value | $2.67B | $25.61B |
Dividend Yield | — | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
